Indaptus Therapeutics, Inc. - stock earnings
INDP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.0 million USD | ? USD |
| 2023Q3 | -3.9 million USD | ? USD |
| 2023Q2 | -3.2 million USD | ? USD |
| 2023Q1 | -4.1 million USD | ? USD |
| 2022Q4 | -3.2 million USD | ? USD |
| 2022Q3 | -3.4 million USD | ? USD |
| 2022Q2 | -3.8 million USD | ? USD |
| 2022Q1 | -3.3 million USD | ? USD |
| 2021Q4 | -3.2 million USD | ? USD |
| 2021Q3 | -3.4 million USD | ? USD |
| 2021Q2 | -7.4 million USD | ? USD |
| 2021Q1 | -612421 USD | ? USD |
| 2020Q4 | -770219 USD | ? USD |
| 2020Q3 | -1.5 million USD | ? USD |
| 2020Q2 | -2.9 million USD | ? USD |
INDP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.4 million USD | ? USD |
| 2022 | -13.7 million USD | ? USD |
| 2021 | -7.7 million USD | ? USD |
| 2020 | -3.6 million USD | ? USD |
| 2019 | -47.6 million USD | ? USD |
INDP
Price: $2.03
52 week price:
Earnings Per Share: -1.83 USD
P/E Ratio: -0.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 19752
Market Capitalization: 23.7 million